To include your compound in the COVID-19 Resource Center, submit it here.

Arrowhead paper reveals additional HBV antigen source

A paper published in Science Translational Medicine by researchers at Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) and colleagues discovered that hepatitis B surface antigen (HBsAg) is expressed from HBV DNA transcripts integrated into the host genome in addition to those from viral covalently closed circular DNA (cccDNA), identifying a previously unrecognized source

Read the full 507 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers